Selcuk University
Konya, Selcuklu/Konya, 42060, Turkey (Türkiye)
NCT Number: NCT05692648
Purpose: The present study was conducted to determine the effect of repositioning frequency during phototherapy on bilirubin level and neonates comfort.
Design and methods: This was a single-centered, single-blind, 3-arm, pretest-posttest parallel-group randomized controlled trial conducted in a neonatal intensive care unit. Participants were randomly assigned to one of three groups: Supine position group (n = 20), hourly position change group (n = 20), and control group (n = 20). The bilirubin level and comfort levels of the neonates were evaluated.
Looking for future studies?
Notify Me35 week–42 week
All sexes
Interventional
Not applicable
Konya, Selcuklu/Konya, 42060, Turkey (Türkiye)
Purpose: The present study was conducted to determine the effect of repositioning frequency during phototherapy on bilirubin level and neonates comfort.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
These neonates were placed in supine position, fed every 2 hours in accordance with routine clinical practice, and then returned to supine position.
Infants in this group were repositioned "every hour" based on the time of phototherapy initiation. Neonates were initially placed in supine position and then changed to the prone position. Infants were alternated between supine and prone positions every hour for 24 hours.
Neonates in this group were repositioned every 2 hours as routine practice based on the time of phototherapy initiation. Phototherapy was started with neonates in supine position. In the second period, the neonate was placed in the prone position after routine feeding was performed.
Time frame: Baseline and 24 hours after phototherapy
bilirubin level change
Time frame: up to 24 hours
comfort level change
Selcuk University
Other
Effect of Repositioning Frequency on Bilirubin Level and Infant Comfort in Neonates Receiving Phototherapy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03259581
Adenocarcinoma, Bilirubinemia
Minneapolis, Minnesota, United States
View Trial DetailsNCT06921330
ABO Incompatibility, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Karabük, Karabük Province, Turkey (Türkiye)
View Trial DetailsNCT06209489
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hyperbilirubinemia
Karabük, Turkey (Türkiye)
View Trial DetailsNCT05121311
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hyperbilirubinemia
Regensburg, Germany
View Trial Details